Reaktionsgleichung
[CH:1]1([CH2:4][O:5][C:6]2[N:11]=[C:10]([C:12]([OH:14])=O)[CH:9]=[CH:8][C:7]=2[O:15][C:16]([F:19])([F:18])[F:17])[CH2:3][CH2:2]1.ClC1N=C(C(O)=O)C=CC=1OCC1CC1.[CH3:35][C:36]1([CH3:41])[CH2:40][O:39][CH2:38][NH:37]1>>[CH:1]1([CH2:4][O:5][C:6]2[N:11]=[C:10]([C:12]([N:37]3[C:36]([CH3:41])([CH3:35])[CH2:40][O:39][CH2:38]3)=[O:14])[CH:9]=[CH:8][C:7]=2[O:15][C:16]([F:19])([F:18])[F:17])[CH2:2][CH2:3]1Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
The title compound was synthesized in analogy to Example 47 b, using the mixture of 6-cyclopropylmethoxy-5-trifluoromethoxy-pyridine-2-carboxylic acid and 6-chloro-5-cyclopropylmethoxy-pyridine-2-carboxylic acid (Example 47 a, 50 mg, 180 μmol) and 4,4-dimethyl-oxazolidine (CAN 51200-87-4; 28.4 μl (75%), 198 μmol) as starting materials and isolated (24 mg, 37%) as colorless oil; LC-MS (UV peak area, ESI) 100%, 361.1370 [MH+].
Aufarbeitung
- customisolated (24 mg, 37%) as colorless oil
Quellen und Nachweise
- ORD-Eintrag
- ord-0860312ac4f74f5186e6d84652ce2168
- Quelldatensatz
- uspto-grants-2016_04
- Patentnummer
- US09303012B2
Verknüpfte Notizen
Wird geladen…